Genomic Health (GHDX) Tops Q4 EPS by 2c, FY15 EPS Misses Consensus
Get Alerts GHDX Hot Sheet
Price: $63.44 --0%
Financial Fact:
Selling and marketing: 116.33M
Today's EPS Names:
WF, CWBC, GLTO, More
Financial Fact:
Selling and marketing: 116.33M
Today's EPS Names:
WF, CWBC, GLTO, More
Join SI Premium – FREE
Genomic Health (NASDAQ: GHDX) reported Q4 EPS of ($0.20), $0.02 better than the analyst estimate of ($0.22). Revenue for the quarter came in at $69.1 million versus the consensus estimate of $72.2 million.
Genomic Health sees FY2015 EPS of ($0.53)-($0.75), versus the consensus of ($0.52). Genomic Health sees FY2015 revenue of $292-305 million, versus the consensus of $310.61 million.
For earnings history and earnings-related data on Genomic Health (GHDX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Alphabet stock surges 11% to record high on Q1 earnings beat, first-ever dividend
- Nomura Holdings (NMR) Reports In-Line Q1 EPS
- Microsoft fiscal Q3 results top estimates as AI revolution spurs cloud growth
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!